go back

Lisocabtagene Maraleucel (Breyanzi)

Rhode Island rates for HCPCS C9076

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $436,516 · 10th–90th $436,516$457,0880%50%90th$436,516Professionalmedian $446,684 · 10th–90th $446,684$446,6840%50%100%$446,684$500.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
BCBS
Setting
Facility
Modifier
Global
Typical Low
$436,515.83
Median
$436,515.83
Typical High
$457,088.19
BCBS
Setting
Professional
Modifier
Global
Typical Low
$446,683.59
Median
$446,683.59
Typical High
$446,683.59